ACT maintains a highly visible, well-regarded presence in the toxicology community through educational programs, professional networking opportunities, and our scientific journal.
Corporate support is essential to the continued success of the College and the achievement of its goals, and the ACT corporate membership program is a highly visible way for companies with a vested interest in the field of toxicology to show their support for the vital work of the College. In return, ACT corporate members benefit by elevating their brand and credibility as an ACT partner.
ACT is a leader in toxicology education, offering well-regarded resources:
ACT members are professional scientists, postdocs, and students representing:
To take advantage of ACT Corporate Membership, please contact Karen Cook, 703.547.0875 ext. 1423.
Altasciences is a drug development solution company offering a flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, and data management.
Learn moreBiomere is a global, nonclinical CRO with locations on the east and west coast, and in China (JOINN). Our personal approach and drive to expedite research timelines, make us ideally suited to support our clients’ needs.
Learn moreGenentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.
Learn moreExpect More: more attention, insight and a superlative experience. Inotiv delivers a comprehensive and integrated range of right-size in vivo discovery and tox services, BioA, pathology, DMPK and consulting solutions essential to your success.
Learn moreLilly unites caring with discovery to create medicines that make life better for people around the world.
Learn moreLovelace Biomedical is a preclinical contract research organization helping pharmaceutical and biotechnology companies advance their complex drug development studies, with multidisciplinary expertise in toxicology, gene therapy, infectious disease, medical countermeasures.
Learn moreHope changes lives. We’re in relentless pursuit of scientific breakthroughs and revolutionary medicines that will create a healthier world for everyone.
Learn moreRegeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. We consistently translate science into medicine, leading to nine FDA-approved treatments and numerous product candidates.
Learn more©Copyright American College of Toxicology All Rights Reserved